Although, in our experimental conditions, we were unable to demonstrate that its overexpression serves as the underlying mechanism driving this adaptive resistance in myeloma cells A possible explanation is that the stable lentiviral overexpression of USP39, which is comparable to the endogenous protein levels, may not be sufficient to counteract the massive lethal effect of BTZ. This evidence concerns the gene USP39 and plasma cell myeloma.